PMDA — authorised 26 June 2015
- Marketing authorisation holder: Kowa Company, Ltd.
- Status: approved
PMDA authorised Livalo on 26 June 2015
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. PMDA authorised it on 26 June 2015.
Kowa Company, Ltd. holds the Japanese marketing authorisation.